Effects of topical carbamylcholine on corneal epithelial resurfacing

A. M. Colley, Harrison D Cavanagh, M. L. Law

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Effects of topical carbamylcholine on resurfacing of epithelial defects produced in both eyes of New Zealand albino rabbits with 18 N H2SO4 were evaluated. One eye of each animal received carbamylcholine (50 μl of a 1.5% solution in HBSS) t.i.d. (10 AM, 1 PM, and 4 PM) for 7 days, with treatment beginning the morning after defect production. The contralateral eye received 50 μl HBSS and served as control. Resurfacing was monitored by fluorescein staining and photography. Rates of resurfacing were calculated by linear regression analysis of plots of defect surface area versus time. Data represent treated and control eyes of 19 animals in two experimental series. In these experiments, carbamylcholine significantly enhanced epithelial resurfacing, although the effect was not dramatic. Mean resurfacing rates were 11.9 ± 1.4 mm2/24 hr for carbamylcholine-treated eyes versus 8.5 ± 1.3 mm2/24 hr for control eyes (p < .001). On each day after initiation of treatment, the mean percentage of original defect area remaining was significantly lower in treated than in control eyes. At the end of the 7-day treatment regimen, none of the defects were completely resurfaced (mean for treated eyes = 79.9 ± 2.2%, mean for control eyes = 56.8 ± 4.3%).

Original languageEnglish (US)
Pages (from-to)71-72
Number of pages2
JournalMetabolic, Pediatric and Systemic Ophthalmology
Volume10
Issue number3
StatePublished - 1987

Fingerprint

Carbachol
Photography
Fluorescein
Linear Models
Regression Analysis
Staining and Labeling
Rabbits

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Ophthalmology
  • Pediatrics, Perinatology, and Child Health

Cite this

Effects of topical carbamylcholine on corneal epithelial resurfacing. / Colley, A. M.; Cavanagh, Harrison D; Law, M. L.

In: Metabolic, Pediatric and Systemic Ophthalmology, Vol. 10, No. 3, 1987, p. 71-72.

Research output: Contribution to journalArticle

@article{45b917418ab64a91b2a610c7bbee1581,
title = "Effects of topical carbamylcholine on corneal epithelial resurfacing",
abstract = "Effects of topical carbamylcholine on resurfacing of epithelial defects produced in both eyes of New Zealand albino rabbits with 18 N H2SO4 were evaluated. One eye of each animal received carbamylcholine (50 μl of a 1.5{\%} solution in HBSS) t.i.d. (10 AM, 1 PM, and 4 PM) for 7 days, with treatment beginning the morning after defect production. The contralateral eye received 50 μl HBSS and served as control. Resurfacing was monitored by fluorescein staining and photography. Rates of resurfacing were calculated by linear regression analysis of plots of defect surface area versus time. Data represent treated and control eyes of 19 animals in two experimental series. In these experiments, carbamylcholine significantly enhanced epithelial resurfacing, although the effect was not dramatic. Mean resurfacing rates were 11.9 ± 1.4 mm2/24 hr for carbamylcholine-treated eyes versus 8.5 ± 1.3 mm2/24 hr for control eyes (p < .001). On each day after initiation of treatment, the mean percentage of original defect area remaining was significantly lower in treated than in control eyes. At the end of the 7-day treatment regimen, none of the defects were completely resurfaced (mean for treated eyes = 79.9 ± 2.2{\%}, mean for control eyes = 56.8 ± 4.3{\%}).",
author = "Colley, {A. M.} and Cavanagh, {Harrison D} and Law, {M. L.}",
year = "1987",
language = "English (US)",
volume = "10",
pages = "71--72",
journal = "Metabolic, pediatric, and systemic ophthalmology",
issn = "0277-9382",
publisher = "Opto Education Corporation",
number = "3",

}

TY - JOUR

T1 - Effects of topical carbamylcholine on corneal epithelial resurfacing

AU - Colley, A. M.

AU - Cavanagh, Harrison D

AU - Law, M. L.

PY - 1987

Y1 - 1987

N2 - Effects of topical carbamylcholine on resurfacing of epithelial defects produced in both eyes of New Zealand albino rabbits with 18 N H2SO4 were evaluated. One eye of each animal received carbamylcholine (50 μl of a 1.5% solution in HBSS) t.i.d. (10 AM, 1 PM, and 4 PM) for 7 days, with treatment beginning the morning after defect production. The contralateral eye received 50 μl HBSS and served as control. Resurfacing was monitored by fluorescein staining and photography. Rates of resurfacing were calculated by linear regression analysis of plots of defect surface area versus time. Data represent treated and control eyes of 19 animals in two experimental series. In these experiments, carbamylcholine significantly enhanced epithelial resurfacing, although the effect was not dramatic. Mean resurfacing rates were 11.9 ± 1.4 mm2/24 hr for carbamylcholine-treated eyes versus 8.5 ± 1.3 mm2/24 hr for control eyes (p < .001). On each day after initiation of treatment, the mean percentage of original defect area remaining was significantly lower in treated than in control eyes. At the end of the 7-day treatment regimen, none of the defects were completely resurfaced (mean for treated eyes = 79.9 ± 2.2%, mean for control eyes = 56.8 ± 4.3%).

AB - Effects of topical carbamylcholine on resurfacing of epithelial defects produced in both eyes of New Zealand albino rabbits with 18 N H2SO4 were evaluated. One eye of each animal received carbamylcholine (50 μl of a 1.5% solution in HBSS) t.i.d. (10 AM, 1 PM, and 4 PM) for 7 days, with treatment beginning the morning after defect production. The contralateral eye received 50 μl HBSS and served as control. Resurfacing was monitored by fluorescein staining and photography. Rates of resurfacing were calculated by linear regression analysis of plots of defect surface area versus time. Data represent treated and control eyes of 19 animals in two experimental series. In these experiments, carbamylcholine significantly enhanced epithelial resurfacing, although the effect was not dramatic. Mean resurfacing rates were 11.9 ± 1.4 mm2/24 hr for carbamylcholine-treated eyes versus 8.5 ± 1.3 mm2/24 hr for control eyes (p < .001). On each day after initiation of treatment, the mean percentage of original defect area remaining was significantly lower in treated than in control eyes. At the end of the 7-day treatment regimen, none of the defects were completely resurfaced (mean for treated eyes = 79.9 ± 2.2%, mean for control eyes = 56.8 ± 4.3%).

UR - http://www.scopus.com/inward/record.url?scp=0023622271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023622271&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 71

EP - 72

JO - Metabolic, pediatric, and systemic ophthalmology

JF - Metabolic, pediatric, and systemic ophthalmology

SN - 0277-9382

IS - 3

ER -